The innovation lab and accelerator created by New Orleans-based Ochsner Health System has entered into a strategic partnership with Evidation Health, a technology and analytics platform, to measure the outcomes of digital health solutions in clinical studies.
innovationOchsner will leverage Evidation Health's platform to study the effectiveness of iO's digital health solutions. Evidation Health, a company launched by GE Ventures and Stanford Health Care, integrates medical, behavioral and contextual data to quantify clinical and economic benefit.
"Our focus in digital health is to demonstrate real-world health outcomes for patients, payers and provider systems, especially in conditions where patient behavior can profoundly impact those outcomes. Our partnership with Ochsner Health System and iO enables connections to a large population of patients and researchers in all types of clinical specialties to demonstrate how these innovative technologies can impact healthcare outcomes and value," said Deborah Kilpatrick, PhD, CEO of Evidation Health.
More articles on innovation:
Healthcare innovation marketplace Lucro seeks to connect buyers, sellers
Outside the hospital: A new business model for healthcare innovation
Cerner questions ousted Mizzou chancellor's role in Tiger Institute